VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ALT
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ALTAltimmune, Inc.
$3.02$267M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksALTQuarterly Financials

Altimmune, Inc. (ALT) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Altimmune, Inc. (ALT) quarterly income statement — complete revenue, gross profit & net income history

ALT Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue026K5K5K5K5K5K5K5K37K362K6K21K-110K2K8K32K3.28M158K137K
Revenue Growth %-100%420%0%0%0%-86.49%-98.62%-16.67%-76.19%133.64%18000%-25%-34.38%-103.36%-98.73%-94.16%-96.18%41.7%-94.62%-81.02%
Cost of Goods Sold23K014.96M00000107K018.39M13.25M019.18M20.26M016.88M21.05M29.21M13.27M
COGS % of Revenue--299200%-----2140%-5079.56%220883.33%--17435.45%1013100%-52762.5%642.2%18484.81%9687.59%
Gross Profit-23K26K-14.96M5K5K5K5K5K-102K37K-18.03M-13.25M21K-19.29M-20.26M8K-16.85M-17.77M-29.05M-13.13M
Gross Margin %-100%-299100%100%100%100%100%100%-2040%100%-4979.56%-220783.33%100%17535.45%-1013000%100%-52662.5%-542.2%-18384.81%-9587.59%
Gross Profit Growth %-560%420%-299200%0%104.9%-86.49%100.03%100.04%-585.71%100.19%11.03%-165687.5%100.12%-8.56%30.25%100.06%-65.87%-39.98%-1088.7%-1920.17%
Operating Expenses24.22M28.92M5.9M22.93M21.82M24.87M24.77M26.75M26.69M33.66M4.51M4.76M21.78M3.81M4.49M20.4M2.65M6.22M4.16M11.73M
OpEx % of Revenue-111226.92%118080%458540%436400%497420%495440%535000%533840%90972.97%1246.96%79333.33%103714.29%-3459.09%224600%255037.5%8271.88%189.72%2630.38%8561.31%
Selling, General & Admin8.05M10.51M5.9M5.69M5.99M5.09M4.97M5.59M5.31M4.33M4.51M4.76M4.53M3.81M4.49M4.41M4.43M3.78M4.16M3.66M
SG&A % of Revenue-40423.08%118080%113820%119860%101800%99380%111900%106240%11708.11%1246.96%79333.33%21576.19%-3459.09%224600%55125%13834.38%115.26%2630.38%2670.8%
Research & Development16.17M18.41M14.96M17.24M15.83M19.78M19.8M21.16M21.49M16.91M18.39M13.25M17.25M19.18M20.26M15.99M15.1M20.18M29.21M13.27M
R&D % of Revenue-70803.85%299200%344720%316540%395620%396060%423100%429740%45700%5079.56%220883.33%82138.1%-17435.45%1013100%199912.5%47200%615.96%18484.81%9687.59%
Other Operating Expenses00-1000K00000-107K1000K-1000K-1000K0-1000K-1000K0-1000K-1000K-1000K-1000K
Operating Income-24.24M-28.89M-20.86M-22.92M-21.82M-24.87M-24.77M-26.75M-26.79M-33.62M-22.54M-18.01M-21.76M-23.09M-24.75M-20.39M-19.5M-23.98M-33.2M-24.86M
Operating Margin %--111126.92%-417180%-458440%-436300%-497320%-495340%-534900%-535880%-90872.97%-6226.52%-300116.67%-103614.29%20994.55%-1237600%-254937.5%-60934.38%-731.92%-21015.19%-18148.91%
Operating Income Growth %-11.13%-16.19%15.78%14.29%18.58%26.04%-9.88%-48.53%-23.14%-45.59%8.94%11.71%-11.59%3.71%25.45%17.97%-31.21%-123.12%-81.2%-35%
EBITDA-24.22M-28.87M-20.83M-22.89M-21.79M-24.83M-24.73M-26.68M-26.69M-31.73M-22.42M-17.88M-21.63M-22.63M-24.74M-20.34M-19.38M-23.87M-32.92M-24.79M
EBITDA Margin %--111026.92%-416640%-457840%-435720%-496660%-494600%-533680%-533740%-85764.86%-6193.09%-298033.33%-103019.05%20574.55%-1237083.35%-254275%-60562.5%-728.35%-20834.81%-18094.16%
EBITDA Growth %-11.18%-16.24%15.76%14.21%18.36%21.74%-10.31%-49.22%-23.36%-40.21%9.39%12.09%-11.63%5.18%24.84%17.94%-31.06%-126.45%-80.36%-35.12%
D&A (Non-Cash Add-back)23K26K27K30K29K33K37K61K107K1.89M121K125K125K462K10.33K53K119K117K285K75K
EBIT-24.24M-28.89M-18.52M-21.88M-20.25M-23.18M-22.84M-24.64M-24.39M-31.64M-22.54M-18.01M-20.07M-23.09M-24.75M-20.04M-21.28M-21.55M-33.2M-16.79M
Net Interest Income1.83M1.56M1.93M868K1.54M1.57M1.9M2.18M2.41M1.96M1.85M1.83M1.67M1.65M989K263K-41K176K-20K11K
Interest Income2.9M2.44M2.43M1.13M1.54M1.57M1.91M2.18M2.41M1.96M1.88M1.83M1.67M1.65M1.05M328K21K176K13K33K
Interest Expense1.07M876K495K264K1K1K6K1K1K2K29K2K2K064K65K62K033K22K
Other Income/Expense1.68M1.53M1.84M776K1.56M1.69M1.92M2.1M2.4M1.98M1.87M1.95M1.69M1.43M1.43M288K69K96K-306K37K
Pretax Income-22.56M-27.36M-19.01M-22.15M-20.26M-23.18M-22.84M-24.64M-24.39M-31.64M-20.67M-16.06M-20.07M-21.66M-23.32M-20.11M-19.43M-23.89M-33.51M-24.83M
Pretax Margin %--105223.08%-380280%-442920%-405120%-463600%-456900%-492800%-487880%-85516.22%-5710.22%-267683.33%-95590.48%19690.91%-1165950.05%-251337.5%-60718.75%-728.99%-21208.86%-18121.9%
Income Tax0000-681K000000000197K00000
Effective Tax Rate %0%0%0%0%3.36%0%0%0%0%0%0%0%0%0%-0.84%0%0%0%0%0%
Net Income-22.56M-27.36M-19.01M-22.15M-19.57M-23.18M-22.84M-24.64M-24.39M-31.64M-20.67M-16.06M-20.07M-21.66M-23.52M-20.11M-19.43M-23.89M-33.51M-24.83M
Net Margin %--105223.08%-380280%-442920%-391500%-463600%-456900%-492800%-487880%-85516.22%-5710.22%-267683.33%-95590.48%19690.91%-1175800%-251337.5%-60718.75%-728.99%-21208.86%-18121.9%
Net Income Growth %-15.26%-18.02%16.77%10.12%19.75%26.74%-10.52%-53.42%-21.52%-46.08%12.1%20.12%-3.31%9.33%29.82%19.01%-30.72%-124.91%-88.57%-48.07%
Net Income (Continuing)-22.56M-27.36M-19.01M-22.15M-19.57M-23.18M-22.84M-24.64M-24.39M-31.64M-20.67M-16.06M-20.07M-21.66M-23.52M-20.11M-19.43M-23.89M-33.51M-24.83M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.18-0.27-0.21-0.27-0.26-0.33-0.32-0.35-0.34-0.54-0.39-0.32-0.37-0.40-0.48-0.42-0.44-0.57-0.81-0.60
EPS Growth %30.77%18.18%34.38%22.86%23.53%38.89%17.95%-9.38%8.11%-35%18.75%23.81%15.91%29.82%40.74%30%-15.79%-111.11%-50%36.17%
EPS (Basic)-0.18-0.27-0.21-0.27-0.26-0.33-0.32-0.35-0.34-0.54-0.39-0.32-0.37-0.40-0.48-0.42-0.44-0.57-0.81-0.60
Diluted Shares Outstanding124.46M100.61M89.42M81.48M75.55M71.26M71.08M70.92M70.8M58.44M53.63M50.69M50.13M50.03M49.29M47.5M43.97M41.71M41.37M41.36M
Basic Shares Outstanding124.46M100.61M89.42M81.48M75.55M71.26M71.08M70.92M70.8M58.25M53.63M50.69M50.13M50.03M48.99M47.5M43.97M41.71M41.37M41.36M
Dividend Payout Ratio--------------------